Taken together, our evidence from transcriptomic, ultrastructural, electrophysiological, and behavioral levels sheds light on a new potential target, NG2 glia, for the treatment of GABA-associated neurologic and anxiety-like neuropsychiatric disorders91. Here, CSPG4 is linked to Anxiety.